Press "Enter" to skip to content

Diabetics stock up on insulin over Brexit fears

Diabetics and insulin providers in Britain are stockpiling the precious medicine to avoid potential shortages in case Britain leaves the European Union without a deal in just over month’s time.

Original source:

Also Read:   Mylan, Biocon launch biosimilar of cancer drug Herceptin in Australia